Scientific publication casts doubt on the arguments of the EU Court of Justice
15 January 2017 / A new scientific publication authored by Testbiotech experts shows that health risks associated with Monsanto’s genetically engineered soybean “Intacta” were not sufficiently assessed. The soybeans produce an insecticide and are resistant to glyphosate and are allowed to imported for use in food and feed in the EU. Health risks arising from interactions between the residues left over from the glyphosate formulations and the insecticide were not investigated despite data showing that toxicity can be thus enhanced.
Mating in natural populations will cause any offspring to die or be seriously mutilated
17 December 2017 / The European Patent Office has granted a patent on genetically engineered insects to Oxitec (EP1984512). The patent covers synthetic DNA sequences purposely engineered to mutilate or kill insects, including insects inheriting the DNA. Once released, the intention is that the insects will mate in natural populations. Any offspring will either be blind, unable to fly, sterile or die at an early stage of their development. In many cases, only the female offspring will be affected, while the males will carry on spreading the genes.
Crucial questions in risk assessment remain unresolved
Thursday, 15 December 2016
Today, the Court of Justice of the EU (CJEU) ruled on legal action brought against the import of genetically engineered Monsanto Intacta soybeans (T-177/13). According to the ruling, these genetically engineered soybeans were risk assessed in accordance with EU regulations. The ruling means that the court has given a stamp of approval to European Food Safety Authority (EFSA) risk assessment and EU Commission decision-making.
Companies have failed to file fully completed applications
Wednesday, 7 December 2016
According to a recent legal dossier, the pending applications for the cultivation of genetically engineered maize in the EU suffer from crucial deficiencies. In consequence, the pending applications must be rejected and the existing authorisation for cultivation of maize MON810 withdrawn. The applications were filed by Monsanto, Pioneer/DuPont and Syngenta. They have wholly ignored recent developments and failed to properly address the risk of the transgenes spreading to other plant species.
English
Deutsch
